News
Recently, Regeneron ( REGN -1.41%) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its ...
11h
Medindia on MSNRegeneron Acquires 23andMe in (Dollar) 256M DealRegeneron acquires 23andMe's genetics services for (Dollar) 256 million * Customer privacy safeguards will remain in place ...
Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?
Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...
5d
Al Jazeera on MSNRegeneron buys 23andMe for $256m after bankruptcyRegeneron Pharmaceuticals has bought the genetic testing company 23andMe, a company once valued at $6bn, for $256m through a ...
Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...
1d
Zacks Investment Research on MSNRegeneron Initial Data on Multiple Myeloma Drug EncouragingRegeneron Pharmaceuticals, Inc. REGN announced encouraging initial results from two cohorts of the early-stage study on ...
SHARJAH, 8th May, 2025 (WAM) -- Rubu’ Qarn for Creating Future Leaders and Innovators is sponsoring the participation of the ...
Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...
Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.
Regeneron Pharmaceuticals yesterday said it will buy genetic testing company 23andMe out of bankruptcy for US$256 million, a ...
On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results